Global Patent Index - EP 2026798 A1

EP 2026798 A1 2009-02-25 - PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS

Title (en)

PHARMACEUTICAL COMPOSITIONS COMPRISING CBX CANNABINOID RECEPTOR MODULATORS AND POTASSIUM CHANNEL MODULATORS

Title (de)

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT CBX CANNABINOID-REZEPTOR-MODULATOREN UND KALIUMKANAL-MODULATOREN

Title (fr)

COMPOSITIONS PHARMACEUTIQUES CONTENANT DES MODULATEURS DE RÉCEPTEURS AUX CANNABINOÏDES CBX ET DES MODULATEURS DE CANAUX POTASSIUM

Publication

EP 2026798 A1 (EN)

Application

EP 07728371 A

Priority

  • EP 2007053914 W
  • EP 06113188 A
  • EP 07728371 A

Abstract (en)

[origin: WO2007125048A1] The invention is directed to pharmaceutical compositions comprising pharmacologically effective quantities of each of a) at least one K<SUB>ATP</SUB> channel modulator as a first active agent and b) at least one CB<SUB>x </SUB>modulator as a second active agent. The invention further relates to the use of such compositions and to methods of treating, preventing, delaying progression of, delaying onset of and/or inhibiting a variety of disease conditions including obesity, diabetes mellitus, metabolic syndrome, syndrome X, insulinoma, familial hyperinsulemic hypoglycemia, male pattern baldness, detrusor hyperreactivity, asthma, neuroprotection, epilepsy, analgesia, cardioprotection, angina, cardioplegia, arrhythmia, coronary spasm, peripheral vascular disease, cerebral vasospasm, appetite regulation, neurodegeneration, pain - including neuropathic pain and chronic pain - and impotence in mammals and humans by administering such compositions to subjects in need thereof. The invention also is directed to processes of manufacturing such compositions.

IPC 8 full level (invention and additional information)

A61K 31/415 (2006.01); A61K 31/045 (2006.01); A61K 31/426 (2006.01); A61P 3/00 (2006.01); A61P 9/00 (2006.01)

CPC (invention and additional information)

A61K 31/045 (2013.01); A61K 31/415 (2013.01); A61K 31/426 (2013.01)

Combination set (CPC)

  1. A61K 31/045 + A61K 2300/00
  2. A61K 31/415 + A61K 2300/00
  3. A61K 31/426 + A61K 2300/00

Citation (search report)

See references of WO 2007125048A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK RS

EPO simple patent family

WO 2007125048 A1 20071108; AR 060625 A1 20080702; AU 2007245733 A1 20071108; BR PI0711064 A2 20110823; CA 2650566 A1 20071108; CN 101431998 A 20090513; EA 200802132 A1 20090630; EP 2026798 A1 20090225; IL 194942 D0 20090803; JP 2009534439 A 20090924; KR 20090007606 A 20090119; MX 2008013678 A 20081104; TW 200808785 A 20080216

INPADOC legal status


2011-05-11 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20101102

2010-08-04 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20100705

2009-02-25 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20081127

2009-02-25 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

2009-02-25 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Countries: AL BA HR MK RS